SCHEMBL14599062

SCHEMBL14599062

CCN(Cc1ccc(OCCc2nc(-c3ccccc3)oc2C)cc1)C(=O)Oc1ccc(OC)cc1

nearest known ligand 0.85

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PPARG P37231 17/20 0.85
PPARA Q07869 16/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13762778 0.94 PPARA (0.76) PPARGPPARA
Muraglitazar SCHEMBL676469 0.92 PPARA (1.00) PPARGPPARA
SCHEMBL6342308 0.90 PPARA (0.87) PPARGPPARA
SCHEMBL6060716 0.89 PPARA (0.81) PPARGPPARA
SCHEMBL13722049 0.89 PPARA (0.93) PPARGPPARA
SCHEMBL13718146 0.88 PPARA (0.93) PPARGPPARA
SCHEMBL8215885 0.88 PPARA (0.88) PPARGPPARA
SCHEMBL13722007 0.87 PPARG (0.69) PPARGPPARA
SCHEMBL13718351 0.87 PPARA (0.89) PPARGPPARA
SCHEMBL6073227 0.86 PPARA (0.90) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070015797-A1 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method CHENG PETER T 2007-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015797-A1 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method GPR119, LIPC, ACACA PPARG 65/4885PPARA 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.